Increased levels of alpha‐1‐acid glycoprotein and interleukin‐6 in refractory depression

Depression

Volumn 3, Issue 4, 1995, Pages 170-175

  Sluzewska, A ^a   Rybakowski, J K ^a   Sobieska, M ^b   Bosnians, E ^c   Pollet, H ^c   Wiktorowicz, K ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c NONE   (Belgium)

Author keywords

alpha 1 acid glycoprotein; interleukin 6; refractory depression

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DOXEPIN; IMIPRAMINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MIANSERIN; MOCLOBEMIDE; OROSOMUCOID;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; ORAL DRUG ADMINISTRATION;

EID: 0029552273     PISSN: 10626417     EISSN: 15227162     Source Type: Journal    
DOI: 10.1002/depr.3050030403     Document Type: Article

References (45)

1. Purification and properties of human plasma endogenous modulator for platelet tricy‐clic binding/serotonin transport complex
2. The dexamethason suppression test as a predictor of antidepres‐sant response
3. Treatment‐resistant depression
4. Crossed immuno‐affinoelectrophoresis: An analytical method to predict the result of affinity chromatogra‐phy
5. Affinity electrophoresis for diagnosis of cancer and inflammatory conditions
6. Cortisol and treatment of depression: Predictive value of spontaneous and suppressed cor‐tisol levels and course of spontaneous plasma cortisol
7. Inhibition of platelet aggregation by native and disialised alpha‐1‐acid glycoprotein
8. Glycan variants of human alpha‐1‐acid glycoprotein modulate the biology of macrophages
9. Treatment refractory depression
10. Contribution to the definition of therapy resistant depressions
11. The clinical meaning of refractory depression: A review for the clinician
12. A rating scale for depression
13. Alpha‐1‐acid glycoprotein in major depressives and eating disorders
14. Elevated levels of acute phase proteins in major depression
15. Increased alpha‐1‐acid glycoprotein in depression lowers free fraction of imipramine
16. Drug binding to human alpha‐1‐acid glycoprotein in health and in disease
17. The acute phase response: An overview
18. Quantitative estimation of proteins by electro phoresis in agarose gel containing antibodies
19. Determination of lectin‐sugar dissociation content by agarose affinity electrophoresis
20. Complex of soluble human IL‐6‐Receptor/IL‐6 upregulate expression of acute phase proteins
21. Evidence for the systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
22. Relationships between interleukin‐6‐activity, acute phase proteins, and function of the hypothalmic‐pituitary‐adrenal axis in severe depression
23. Poor response to antidepressants and dexam‐ethasone nonsuppression
24. The biological basis of refractory depression
25. Response to steroid suppression in major depression resistant to antidepressant therapy
26. Interleukin‐1 and −6 stimulate the release of corticotropin‐realising hormone 41 from rat hypo‐thalmus in vitro via the ecosanoid cyclooxygenase pathway
27. Elevated plasma concentration of alpha‐1‐acid glycoprotein, a putative endogenous inhibitor of tritiated imipramine binding site in depressed patients
28. Treatment resistant depression: Definition and treatment approaches
29. Microheterogeneity of alpha‐1‐acid glycoprotein in detection of intercurrent infection in rheumatoid arthritis
30. Glycosylation of four acute‐phase glycoproteins secreted by rat liver cells in vivo and in vitro. Effects of inflammation and dexamethasone
31. Con A‐nonreactive human alpha‐1‐acid glycoprotein (AGP) is more effective in modulation of limphocyte proliferation than Con A‐reactive AGP serum variants
32. Recent views on treatment‐resistant depression
33. Cortisol levels and immuno‐logical indices in depression
34. Concentration and microheterogeneity of alpha‐1‐acid glycoprotein and alpha‐1‐antichymotrypsin in depressed patients during fluoxetine treatment
35. Interleukin‐6 serum levels in depressed patients before and after treatment with fluoxetine
36. Changes in plasma proteins in depressed patients and rodent model of depression
37. Prostaglandin dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins
38. N‐Glycosylation of serum proteins in disease and its investigation using lectins
39. Control of glycosylation alterations of acute phase glycoproteins
40. Changes in glycosylation of acute‐phase proteins in health and disease: Occurrence, regulation and function
41. Effects of alpha‐1‐acid glycoprotein on human poly‐nuclear neutrophils: Influence of glycan microheterogeneity